Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 34 results found. Search for [ remdesivir medicine price ]

Results 1 to 21 of 34
PTI
May 3, 2021
Petitioner Dincur Bajaj said since the export of Remdesivir has been banned by the Centre, the companies which were producing it for export be permitted to manufacture and sell it in the domestic market


BusinessToday.In
May 3, 2021
The company is ready to launch the product this week, so as to make the product available to suffering patients across India


BusinessToday.In
May 2, 2021
The court said it has been informed by the Centre that NPPA has revised the maximum retail price of Remdesivir to Rs 3,500.


BusinessToday.In
April 21, 2021
This customs duty waiver will remain in effect till October 31, 2021, and is among the measures to increase the production and supply of the anti-COVID-19 drug as infections rise rapidly


BusinessToday.In
April 17, 2021
The National Pharmaceutical Pricing Authority under the Department of Pharmaceuticals declared change in prices for seven brands of Remdesivir injections of potency 100mg per vial


BusinessToday.In
April 9, 2021
Mumbai Police's crime branch nabbed a person with 12 Remdesivir vials on Thursday. Following this, several late-night raids were carried out, during which the cops seized more than 272 Remdesivir injections from one GR Pharma shop


Joe C Mathew
October 7, 2020
Parallel to the WTO proposal, SJM wants India to initiate measures under Section 66 of the Patents Act for the cancelation of the patent on Remdesivir


Reuters
September 12, 2020
The Food and Drug Administration has allowed more liberal remdesivir use, but 6 out of 8 major hospital systems contacted by Reuters said they were not using it for moderate cases


Reuters
August 13, 2020
Zydus has priced it at 2,800 rupees ($37.44) per 100mg vial. It will be sold under the brand name Remdac to government and private hospitals treating COVID-19 patients


BusinessToday.In
July 20, 2020
Remdesivir is one of the few medicines believed to be effective in treating coronavirus patients. So far, it has secured approvals for emergency use from US FDA and conditional approval from the European Commission.


BusinessToday.In
July 11, 2020
Remdesivir black marketing: The accused were caught red-handed while selling the medicine and the police also recovered four vials


www.businesstoday.in
New Delhi, July 9, 2020
The Drug Controller General of India (DCGI) has directed the department officials in states and union territories to keep strict vigil and prevent the black marketing of COVID-19 treatment drug Remdesivir, following complaints of the medicine being sold above the Maximum Retail Price (MRP) to the public. The complaints said that the drug costing Rs 5400 per vial was being sold for Rs 15,000 to Rs 60,000 in the black market. Watch the video for more.Tamil Nadu shop owner claims to cure coronavirus with Mysoorpa sweet; FSSAI cancels licence


BusinessToday.In
New Delhi, July 8, 2020
The Trump administration has formally notified the United Nations of its decision to withdraw the US from the World Health Organisation, officials said, breaking off ties with the global health body amid the expanding coronavirus pandemic; ICICI Bank plans to reward more than 80,000 of its employees for working during the coronavirus pandemic; The Drug Controller General of India has directed the department officials in states and union territories to keep strict vigil and prevent black marketing of COVID-19 treatment drug Remdesivir, following complaints of the medicine being sold above the Maximum Retail Price to the public. Watch this and more on News Blast.Also Read: Cipla share gains 2% on plan to launch own version of Remdesivir


BusinessToday.In
New Delhi, July 8, 2020
Trump administration formally informs UN of decision to pull out of WHOThe Trump administration has formally notified the United Nations of its decision to withdraw the US from the World Health Organization, officials said, breaking off ties with the global health body amid the expanding coronavirus pandemic. The US has accused the WHO of siding with China on the outbreak of the virus, which originated in the Chinese city of Wuhan late last year, alleging the health body misled the world res...


PB Jayakumar
July 8, 2020
Various medical shops have been telling buyers that the medicine is in short supply but can be made available If they are ready to pay a premium, DCGI has been informed


Joe C Mathew
July 7, 2020
DGCI has asked all state drug controllers to instruct their field officials to keep strict vigil to prevent black marketing and unauthorised sale of remdesivir


BusinessToday.In
July 6, 2020
Mylan has been licensed by Gilead for marketing the drug in 127 low- and middle-income countries, including India. The company will manufacture remdesivir at its injectables facilities in India


Reuters
July 4, 2020
A week ago, European Medicines Agency gave its go-ahead for remdesivir to be used in adults and adolescents from 12 years of age who are also suffering from pneumonia and require oxygen support


PTI
July 1, 2020
Fujifilm is conducting a clinical study on Avigan to treat COVID-19 patients in Japan and the United States and has been seeking to increase the drug's production by partnering with domestic and overseas companies


BusinessToday.In
June 30, 2020
In the US, federal health officials have allocated the limited supply to states, but that agreement with Gilead will end after September


PAGES 1 OF 2  12